Age-related macular degeneration (AMD) is a disease of the retinas that is the most common cause of vision loss in people over 65 years old. It can impact you as early, however, as 40 years of age and is one of the common eye conditions that you should be screened for every year with a comprehensive eye examination. There was a time when there was no way to effectively treat it, but at The Retina Group of Washington, we have the state-of-the-art technology of CentraSight to help you. It’s an implanted medical device that our retina surgeon in Alexandria can provide.
As AMD progresses, it begins to compromise your central eyesight, leaving a huge blind spot in the center of your field of vision. CentraSight is not for everyone who has AMD, but if you meet the following qualifications, then it might be right for you: first, you need to be in the end-stage of AMD in both eyes. Also, you should no longer be able to get results from drug treatment for the disease, nor have had cataract surgery in the eye that will be getting the implant. You should also be within certain limits of age, vision, and corneal health. These are all things that our retina surgeon in Alexandria will determine as part of your exam and consultation. Various testes will be done, including the use of an external telescope simulator. By the conclusion of your appointment, you will know if you can benefit from CentraSight.
After our retina surgeon in Alexandria has implanted the device, which is the size of a pea, you will achieve your central vision from that eye and your other eye will provide your side-to-side (or peripheral) vision. This is an exciting development in the field of retinal care for anyone with advanced AMD. Instead of simply managing the disease and learning to live with it, CentraSight brings with it the very real possibility of restoring your vision to a level that would have previously been unthinkable. Why not call us today and schedule a session to discover if you can take advantage of this fantastic advancement in the treatment of AMD.